PRMT2 and breast cancer: The increased expression of the total amount of PRMT2 reported in breast cancer tissue could be explained by the high level of PRMT2 in the cytoplasm, since PRMT2 is clearly decreased in cell nuclei compared with normal breast tissue [58].